BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Borkiewicz L. Histone 3 Lysine 27 Trimethylation Signature in Breast Cancer. Int J Mol Sci 2021;22:12853. [PMID: 34884658 DOI: 10.3390/ijms222312853] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu L, Zheng W, Gao Q, Chen T, Pan Z, Cui W, Cai M, Fang H. Epigenetics and genetics of hepatoblastoma: Linkage and treatment. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1070971] [Reference Citation Analysis]
2 Rajendran P, Abdelsalam SA, Renu K, Veeraraghavan V, Ben Ammar R, Ahmed EA. Polyphenols as Potent Epigenetics Agents for Cancer. IJMS 2022;23:11712. [DOI: 10.3390/ijms231911712] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Xu K, Liu X, Wen B, Liu Y, Zhang W, Hu X, Chen L, Hang W, Chen J. GSK-J4, a Specific Histone Lysine Demethylase 6A Inhibitor, Ameliorates Lipotoxicity to Cardiomyocytes via Preserving H3K27 Methylation and Reducing Ferroptosis. Front Cardiovasc Med 2022;9:907747. [DOI: 10.3389/fcvm.2022.907747] [Reference Citation Analysis]
4 Lacombe V, Lenaers G, Urbanski G. Diagnostic and Therapeutic Perspectives Associated to Cobalamin-Dependent Metabolism and Transcobalamins’ Synthesis in Solid Cancers. Nutrients 2022;14:2058. [DOI: 10.3390/nu14102058] [Cited by in F6Publishing: 1] [Reference Citation Analysis]